| 发明名称 |
SULFURIC ACID MONO-[3-({1-[2-(4-FLUORO-PHENYL)-ETHYL]-PIPERIDIN-4-YL}-HYDROXY-METHYL)-2-METHOXY-PHENYL]ESTER |
| 摘要 |
The present invention is directed to sulfuric acid mono-[3-({1-[2-(4-fluoro- phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester a metabolite of the 5HT2A antagonist (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4 - fluorophenyl)ethyl]-4-piperidinemethanol and a processes for its preparation and its use in the treatment for a number of disease states.
|
| 申请公布号 |
CA2374635(C) |
申请公布日期 |
2007.04.17 |
| 申请号 |
CA20002374635 |
申请日期 |
2000.07.13 |
| 申请人 |
AVENTIS PHARMACEUTICALS INC. |
发明人 |
BERNOTAS, RONALD CHARLES;BROWN, PAUL WAYNE;EMMONS, GARY THOMAS;KING, CHI-HSIN RICHARD |
| 分类号 |
C07D211/22;A61K31/44;A61K31/445;A61P1/14;A61P7/00;A61P7/02;A61P9/00;A61P9/06;A61P9/10;A61P25/00;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P43/00;C07D211/32;C07F7/18 |
主分类号 |
C07D211/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
